Changes afoot in York, last place in UK not to fund IVF
The Vale of York Clinical Commissioning Group has agreed in principle to fund IVF treatment for couples in the area, although a formal decision on the matter will be made at a later date....
by Purvi Shah
The Vale of York Clinical Commissioning Group has agreed in principle to fund IVF treatment for couples in the area, although a formal decision on the matter will be made at a later date....
The lead author of a controversial study describing a new type of stem cell - stimulus-triggered acquisition pluripotency (STAP) cells - has agreed to retract two research papers published in the journal Nature in January 2014...
Research on mouse fur colour has shown that a single-letter DNA change — the smallest possible change in DNA — can account for the variation in hair colour that produces blonde hair in humans...
Cannabis use affects thesize and shape of sperm, according to a large study on lifestyle choices, environmental factors and semen quality...
A bill permitting same-sex couples and single men and women to use surrogacy in Israel has been approved by the Israeli Cabinet. The bill now needs to be passed by Israel's parliament, the Knesset, before it can become law...
by Isobel Steer
Human embryonic stem cells have been shown to be more effective in treating multiple sclerosis (MS) in mice than bone marrow stem cells, a study has found...
by Alice Plein
Two experimental IVF techniques that could prevent certain types of incurable genetic disease are 'not unsafe', a report from the UK's Human Fertilisation and Embryology Authority has found....
Smokers are more likely to develop lung cancer if they carry a defective version of a gene associated with breast cancer, a study has found...
This Royal Institution event questions why so many of us overeat despite the huge amount of information available on appropriate calorie intake, and the biological factors that control our insatiable appetites for food...
Comment
Risk Management: Breast Cancer, Business and Patents
by Simon Hazelwood-Smith
The backdrop to the third event in the Progress Educational Trust's 'Breast Cancer: Chances, Choices and Genetics' series was the Myriad Genetics gene patenting legal saga, which came to a conclusion last year with Myriad being denied a patent on the isolated forms of the BRCA genes...